← Back to SER

Serina Therapeutics, Inc. Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 14/05/2026Sep 2025Filed 13/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 14/05/2026Sep 2024Filed 13/11/2025Jun 2024Filed 11/08/2025Mar 2024Filed 08/05/2025
$0$0$0.1$0$0$0.1$0
−$6.4−$6.9−$4.6−$6.4−$4.8$1.4$5.2−$15
−$0.55−$0.58−$0.45−$0.66−$0.49$0.13$0.51−$5.38
161210109.811102.8

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.